Prognosis
U.S. Cases Increase 4.4%; Gilead Drug Gets FDA Nod: Virus Update
This article is for subscribers only.
Gilead Sciences Inc.’s antiviral drug remdesivir was cleared by U.S. regulators for emergency use in Covid-19 patients, becoming the first medication backed by early clinical data to be made available to fight the novel coronavirus.
Florida plans to reopen its state parks on May 4 as part of a broader move to start relaxing controls. New York Governor Andrew Cuomo said the state’s schools would remain closed for the remainder of the academic year.